{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:11:31Z","timestamp":1761487891085},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11864-001-0071-z","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T18:23:48Z","timestamp":1184610228000},"page":"495-506","source":"Crossref","is-referenced-by-count":47,"title":["Low-grade gliomas"],"prefix":"10.1007","volume":"2","author":[{"given":"Volker W.","family":"Stieber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"71_CR1","unstructured":"Statistical Report: primary brain tumors in the United States, 1992\u20131997.\n                           Central Brain Tumor Registry of the United States 2000, Current epidemiological data."},{"key":"71_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"G Woolam","year":"2000","unstructured":"Woolam G: Cancer Statistics, 2000: a benchmark for the new century. CA Cancer J Clin 2000, 50:7\u201333. Current epidemiological data.","journal-title":"CA Cancer J Clin"},{"key":"71_CR3","first-page":"152","volume":"3","author":"FG Davis","year":"2001","unstructured":"Davis FG, Kupelian V, Freels S, et al.: Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncol 2001, 3:152\u2013158.","journal-title":"Neuro-Oncol"},{"key":"71_CR4","volume-title":"Classification of Tumours, Pathology and Genetics of Tumours of the Nervous System","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Classification of Tumours, Pathology and Genetics of Tumours of the Nervous System. Edited by Kleihues P, Cavence WK. Lyon, France: IARC Press; 2000. This is the international standard of pathologic classification of primary brain tumors, recently updated."},{"key":"71_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1215\/15228517-3-3-141","volume":"3","author":"PJ Jukich","year":"2001","unstructured":"Jukich PJ, McCarthy BJ, Surawicz TS, et al.: Trend in incidence of primary brain tumors in the United States, 1985-1994. Neuro-Oncol 2001, 3:141\u2013151.","journal-title":"Neuro-Oncol"},{"key":"71_CR6","volume-title":"An Encyclopedic Approach","author":"Brain Tumors","year":"2001","unstructured":"Brain Tumors: An Encyclopedic Approach, edn. 2. Edited by Kaye AH, Laws ER. London, UK: Churchill Livingstone; 2001.","edition":"edn. 2"},{"key":"71_CR7","volume-title":"Cancer of the Nervous System","year":"1997","unstructured":"Cancer of the Nervous System, edn. 1. Edited by Black PM, Loeffler JS. Boston: Blackwell Science; 1997.","edition":"edn. 1"},{"key":"71_CR8","volume-title":"The Gliomas.","year":"1999","unstructured":"The Gliomas. Edited by Berger M, Wilson C. Philadelphia: WB Saunders; 1999."},{"key":"71_CR9","volume-title":"The Practical Management of Low-Grade Primary Brain Tumors","year":"1999","unstructured":"The Practical Management of Low-Grade Primary Brain Tumors. Edited by Rock JP, Rosenblum M, Shaw E, Cairncross J. Philadelphia: Lippincott Williams & Wilkins; 1999."},{"key":"71_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/srao.2001.21411","volume":"2","author":"E Shaw","year":"2001","unstructured":"Shaw E: Low Grade Gliomas. Sem Radiat Oncol 2001, 2:93\u2013180. Comprehensive recent overview of the management of low-grade gliomas.","journal-title":"Sem Radiat Oncol"},{"key":"71_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3171\/jns.1984.61.4.0665","volume":"61","author":"ER Laws","year":"1984","unstructured":"Laws ER Jr, Taylor WF, Clifton MB, et al.: Neurosurgical management of low-grade astrocytomas of the cerebral hemispheres. J Neurosurg 1984, 61:665\u2013673.","journal-title":"J Neurosurg"},{"key":"71_CR12","first-page":"401a","volume":"17","author":"E Shaw","year":"1998","unstructured":"Shaw E, Arusell R, Scheithauer B, et al.: A prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade gliomas: initial report of a NCCTG-RTOG-ECOG study abstract]. Proc ASCO 1998, 17:401a. Phase III trial that examines the question of radiotherapy dose.","journal-title":"Proc ASCO"},{"key":"71_CR13","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1200\/JCO.1997.15.9.3129","volume":"15","author":"K Lote","year":"1997","unstructured":"Lote K, Egeland T, Hagar B, et al.: Survival, prognostic factors, and therapeutic efficacy in low-grade gliomas: a retrospective study in 379 patients. J Clin Oncol 1997, 15:3129\u20133140.","journal-title":"J Clin Oncol"},{"key":"71_CR14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/jns.1989.70.6.0853","volume":"70","author":"EG Shaw","year":"1989","unstructured":"Shaw EG, Daumas-Duport C, Scheithauer BW, et al.: Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989, 70:853\u2013861.","journal-title":"J Neurosurg"},{"key":"71_CR15","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D","volume":"74","author":"M Berger","year":"1994","unstructured":"Berger M, Deliganis A, Dobbins J, et al.: The effect of extent of resection on recurrence in patients with low-grade cerebral hemisphere gliomas. Cancer 1994, 74:1784\u20131791.","journal-title":"Cancer"},{"key":"71_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0360-3016(99)00284-9","volume":"45","author":"G Bauman","year":"1999","unstructured":"Bauman G, Lote K, Larso D, et al.: Pretreatment factors predict overall survival for patients with low-grade gliomas:a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1999, 45:923\u20139239. Recent recursive partitioning analysis of prognostic factors.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"71_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/canjclin.51.3.153","volume":"51","author":"J Brown","year":"2001","unstructured":"Brown J, Byers T, Thompson K, et al.: Nutrition during and after cancer treatment: a guide for informed choices by cancer survivors. CA Cancer J Clin 2001, 51:153\u2013187.","journal-title":"CA Cancer J Clin"},{"key":"71_CR18","first-page":"1","volume":"3","author":"National Radiological Protection Board","year":"1992","unstructured":"National Radiological Protection Board: Electromagnetic fields and the risk of cancer. National Radiological Protection Board, Report of an advisory group on non-ionising radiation. Doc NRBP 1992, 3:1\u2013138.","journal-title":"Doc NRBP"},{"key":"71_CR19","first-page":"189","volume-title":"Brain Tumors: An Encyclopedic Approach","author":"GG Giles","year":"2001","unstructured":"Giles GG, Gonzales MF: Epidemiology of brain tumors and factors in prognosis. In Brain Tumors: An Encyclopedic Approach, edn. 2. Edited by Kaye AH, Laws ER. London, UK: Churchill Livingstone, 2001:189\u2013215.","edition":"edn. 2"},{"key":"71_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/srao.2001.21420","volume":"11","author":"PE Ricci","year":"2001","unstructured":"Ricci PE, Dungan DH: Imaging of low- and intermediate-grade gliomas. Sem Radiat Oncol 2001, 11:103\u2013112. Useful summary of diagnostic imaging criteria.","journal-title":"Sem Radiat Oncol"},{"key":"71_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000115757","volume":"24","author":"R Leiguarda","year":"1985","unstructured":"Leiguarda R, Sierra J, Pardal C, et al.: Effect of large doses of methylprednisolone on supratentorial intracranial tumors. A clinical and CAT scan evaluation. Eur Neurol 1985, 24:23\u201332.","journal-title":"Eur Neurol"},{"key":"71_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4615-7255-8_2","volume-title":"Implications of the Blood-brain Barrier and its Manipulation.","author":"K Yamada","year":"1989","unstructured":"Yamada K, Ushio Y, Hayakawa T: Effects of steroid on the blood brain barrier. In Implications of the Blood-brain Barrier and its Manipulation. Edited by Neuwelt EA. New York: Plenum Press, 1989;1:53\u201376."},{"key":"71_CR23","first-page":"189","volume-title":"Brain Tumors: An Encyclopedic Approach","author":"K Thapar","year":"2001","unstructured":"Thapar K, Taylor MD, Laws ER, et al.: Brain edema, increased intracranial pressure, and vascular effects of human brain tumors. In Brain Tumors: An Encyclopedic Approach edn. 2. Edited by Kaye AH, Laws ER. London, UK: Churchill Livingstone, 2001:189\u2013215.","edition":"edn. 2"},{"key":"71_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/srao.2001.21430","volume":"11","author":"SB Tatter","year":"2001","unstructured":"Tatter SB: Neurosurgical management of low- and intermediate-grade gliomas. Semin Radiat Oncol 2001, 11:113\u2013123. Comprehensive overview of surgical management of low-grade gliomas.","journal-title":"Semin Radiat Oncol"},{"key":"71_CR25","first-page":"309","volume-title":"Neurological and Neurosurgical Intensive Care","author":"M Bilsky","year":"1993","unstructured":"Bilsky M, Posner JB: Intensive and postoperative care of intracranial tumors. In Neurological and Neurosurgical Intensive Care, edn. 3. Edited by Ropper AH. New York: Raven Press, 1993:309\u2013329.","edition":"edn. 3"},{"key":"71_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0317167100030419","volume":"17","author":"RF Del Maestro","year":"1990","unstructured":"Del Maestro RF, Megyesi JF, Farrell CL: Mechanisms of tumor-associated edema: a review. Can J Neurol Sci 1990, 17:177\u2013183.","journal-title":"Can J Neurol Sci"},{"key":"71_CR27","first-page":"53a","volume":"20","author":"SA Grossman","year":"2001","unstructured":"Grossman SA, Suleman S, Eller S, et al.: Novel COX-2 inhibitor is equal to dexamethasone in prolonging survival in rats with 9L gliomas. Proc ASCO 2001, 20:53a.","journal-title":"Proc ASCO"},{"key":"71_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1053\/srao.2001.21421","volume":"11","author":"GA Watson","year":"2000","unstructured":"Watson GA, Kadota RP, Wisoff JH: Multidisciplinary management of pediatric low-grade gliomas. Semin Radiat Oncol 2000, 11:152\u2013162.","journal-title":"Semin Radiat Oncol"},{"key":"71_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1005715405413","volume":"34","author":"M Berger","year":"1997","unstructured":"Berger M, Rostomily R: Low-grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol 1997, 34:85\u2013101.","journal-title":"J Neurooncol"},{"key":"71_CR30","first-page":"660","volume-title":"The Gliomas.","author":"M Berger","year":"1999","unstructured":"Berger M, Wilson C: Extent of resection and outcome for cerebral hemispheric gliomas. In The Gliomas. Edited by Berger M, Wilson C. London, UK: WB Saunders, 1999:660\u2013679."},{"key":"71_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3171\/jns.1995.82.4.0523","volume":"82","author":"LD Lunsford","year":"1995","unstructured":"Lunsford LD, Somaza S, Kondziolka D, Flickinger JC: Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J Neurosurg 1995, 82:523\u2013529.","journal-title":"J Neurosurg"},{"key":"71_CR32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3171\/jns.1988.68.5.0684","volume":"68","author":"KE Wallner","year":"1988","unstructured":"Wallner KE, Gonzales M, Sheline GE. Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 1988, 68:684\u2013688.","journal-title":"J Neurosurg"},{"key":"71_CR33","first-page":"400a","volume":"17","author":"AB Karim","year":"1998","unstructured":"Karim AB, Cornu N, Bleheem D, et al.: Immediate postoperative radiotherapy in low-grade gliomas improves progression free survival, but not overall survival: preliminary results of an EORTC\/MRC randomized phase III study. Proc ASCO 1998, 17:400a. Phase III trial that examines the need for adjuvant radiotherapy.","journal-title":"Proc ASCO"},{"key":"71_CR34","first-page":"S58","volume":"58","author":"M Bolla","year":"2001","unstructured":"Bolla M. EORTC trials: a bridge between two millennia abstract]. Radiother Oncol 2001, 58:S58.","journal-title":"Radiother Oncol"},{"key":"71_CR35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3171\/jns.1987.67.2.0224","volume":"67","author":"KF Lindegaard","year":"1987","unstructured":"Lindegaard KF, Mork SJ, Eide GE, et al.: Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg 1987, 67:224\u2013230.","journal-title":"J Neurosurg"},{"key":"71_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0360-3016(96)00352-5","volume":"36","author":"A Karim","year":"1996","unstructured":"Karim A, Maat B, Hatlevoll R, et al.: A randomized trial of dose-response in radiation therapy of low-grade gliomas: EORTC Study 22844. Int J Radiat Oncol Biol Phys 1996, 36:549\u2013556. This phase III trial examines the question of radiotherapy dose.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"71_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/1097-0142(19900701)66:1<6::AID-CNCR2820660103>3.0.CO;2-F","volume":"66","author":"CA North","year":"1990","unstructured":"North CA, North RB, Epstein JA, et al.: Low-grade cerebral astrocytomas: survival and quality of life after radiation therapy. Cancer 1990, 66:6\u201314.","journal-title":"Cancer"},{"key":"71_CR38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000411642","volume":"29","author":"JE Marks","year":"1985","unstructured":"Marks JE, Wong I: The risk of cerebral radionecrosis in relation to dose, time and fractionation: a follow-up study. Prog Exp Tumor Res 1985, 29:210\u2013218.","journal-title":"Prog Exp Tumor Res"},{"key":"71_CR39","first-page":"151","volume":"14","author":"J Hammack","year":"1995","unstructured":"Hammack J, Shaw E, Ivnik R, et al.: Neurocognitive function in patients receiving radiation therapy for supratentorial low-grade gliomas: a North Central Cancer Treatment Group prospective study abstract]. Proc ASCO 1995, 14:151. Examines a subgroup of patients from a phase II randomized prospective trial for cognitive deficits from radiotherapy.","journal-title":"Proc ASCO"},{"key":"71_CR40","first-page":"58a","volume":"20","author":"PD Brown","year":"2001","unstructured":"Brown PD, Buckner JC, Brown CA, et al.: The effects of radiation on cognitive function in patients with lowgrade gliomas. Proc ASCO 2001, 20:58a. Examines a subgroup of patients from a phase II randomized prospective trial for cognitive deficits from radiotherapy.","journal-title":"Proc ASCO"},{"key":"71_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3171\/jns.1993.78.6.0909","volume":"78","author":"HJ Eyre","year":"1993","unstructured":"Eyre HJ, Eltringham JR, Crowley J, et al.: A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: Southwest Oncology Group Study. J Neurosurg 1993, 78:909\u2013914. Phase III trial that demonstrates the lack of efficacy of single-agent chemotherapy.","journal-title":"J Neurosurg"},{"key":"71_CR42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.51.4.1140","volume":"51","author":"MJ Van den Bent","year":"1998","unstructured":"Van den Bent MJ, Kros JM, Heimans JJ, et al.: Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Neurol 1998, 51:1140\u20131145.","journal-title":"Neurol"},{"key":"71_CR43","first-page":"140","volume":"18","author":"JC Buckner","year":"1999","unstructured":"Buckner JC, Smith JS, Nelson DF, et al.: Phase II trial of procarbazine, CCNU, and vincristine (PCV) as initial therapy in patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy results and associations with chromosome 1p and 19q loss abstract]. Proc ASCO 1999, 18:140.","journal-title":"Proc ASCO"},{"key":"71_CR44","first-page":"410","volume":"16","author":"L Thoron","year":"1997","unstructured":"Thoron L, Colinskas C, McDevitt K, et al.: Adjuvant I-PCV chemotherapy for treatment of low-grade oligodendroglioma. Proc Am Soc Clin Oncol 1997, 16:410.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"71_CR45","first-page":"316","volume":"102","author":"L Leksell","year":"1951","unstructured":"Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951, 102:316\u2013319. Seminal paper from the inventor of the Elekta Gamma Knife and modern radiosurgery.","journal-title":"Acta Chir Scand"},{"key":"71_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0090-3019(89)90135-3","volume":"32","author":"WA Friedman","year":"1989","unstructured":"Friedman WA, Bova FJ: The University of Florida radiosurgery system. Surg Neurol 1989, 32:334\u2013342.","journal-title":"Surg Neurol"},{"key":"71_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291\u2013298. Landmark radiosurgery dose-escalation trial.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"71_CR48","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0360-3016(99)00539-8","volume":"47","author":"J van Rijn","year":"2000","unstructured":"van Rijn J, Heimans JJ, van den Berg J, et al.: Survival of human glioma cells treated with various combination of temozolomide and x-rays. Int J Radiat Oncol Biol Phys 2000, 47:779\u2013784.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"71_CR49","first-page":"52a","volume":"20","author":"MJ van den Bent","year":"2001","unstructured":"van den Bent MJ, Chinot O, Boogerd W, et al.: EORTC study 26972: second line temozolomide chemotherapy in recurrent oligodendroglial tumors after PCV chemotherapy. Proc ASCO 2001, 20:52a.","journal-title":"Proc ASCO"},{"key":"71_CR50","first-page":"169","volume":"19","author":"AH Friedman","year":"2000","unstructured":"Friedman AH, Cokgor I, Edward S, et al.: Phase II treatment of anaplastic oligodendroglioma and low-grade gliomas with temozolomide. abstract]. Proc ASCO 2000, 19:169.","journal-title":"Proc ASCO"},{"key":"71_CR51","first-page":"167","volume":"19","author":"L Viviers","year":"2000","unstructured":"Viviers L, Brada M, Hines F, et al.: A phase II trial of primary chemotherapy with temozolomide in patients with low-grade cerebral gliomas abstract]. Proc ASCO 2000, 19:167.","journal-title":"Proc ASCO"},{"key":"71_CR52","first-page":"S58","volume":"58","author":"L Viviers","year":"2001","unstructured":"Viviers L, Murphy P, Britton J, et al.: A phase II trial of primary chemotherapy with temozolomide in patients with low-grade cerebral gliomas. Radiother Oncol 2001, 58:S58.","journal-title":"Radiother Oncol"},{"key":"71_CR53","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1038\/sj.onc.1202759","volume":"18","author":"JS Smith","year":"1999","unstructured":"Smith JS, Alderet B, Minn T, et al.: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999, 18:4144\u20134152.","journal-title":"Oncogene"},{"key":"71_CR54","first-page":"1175","volume":"145","author":"J Reifenberger","year":"1994","unstructured":"Reifenberger J, Reifenberger G, Liu L, et al.: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994, 145:1175\u20131190.","journal-title":"Am J Pathol"},{"key":"71_CR55","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","volume":"90","author":"JG Cairncross","year":"1998","unstructured":"Cairncross JG, Ueki K, Zlatescu MC, et al.: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroglioma. J Natl Cancer Inst 1998, 90:1473\u20131479.","journal-title":"J Natl Cancer Inst"},{"key":"71_CR56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","volume":"18","author":"JS Smith","year":"2000","unstructured":"Smith JS, Perry A, Borell TJ, et al.: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000, 18:636\u2013645.","journal-title":"J Clin Oncol"},{"key":"71_CR57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9440(10)65134-6","volume":"155","author":"SH Bigner","year":"1999","unstructured":"Bigner SH, Matthews MR, Rasheed BK, et al.: Molecular genetic aspects of oligodendrogliomas including analysis of comparative genomic hybridization. Am J Pathol 1999, 155:375\u2013386.","journal-title":"Am J Pathol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0071-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-001-0071-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0071-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0071-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T19:32:19Z","timestamp":1652643139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-001-0071-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1007\/s11864-001-0071-z","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}